Effects of Peiminine on biological behavior and chemotherapy resistance of ovarian cancer by regulating the FOXO3-FOXM1 signaling axis (PubMed, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi)
Methods Ovarian cancer cells SKOV3 and SKOV3/cisplatin (DDP) were used as research objects...SKOV3/DDP cells were divided into control group (normal culture), DDP group (20 μg/mL DDP), L-PMI group, M-PMI group, H-PMI group (20 μg/mL DDP+50, 100, 200 μmol/L PMI), and carbenoxolone (CBX) group (20 μg/mL DDP+200 μmol/L PMI+50 ng/mL CBX)...The number of clonal cells, invasive cells, and migrating cells, the protein expressions of PCNA, MRP5 and FOXM1 in CBX group were higher than those in H-PMI group, and the apoptotic rate, the protein expressions of Caspase-3 and FOXO3 in CBX group were lower than those in H-PMI group. Conclusion PMI may activate FOXO3 and inhibit FOXM1, thereby suppressing the proliferation, invasion, migration, and chemotherapy resistance of ovarian cancer cells.